News

Immuron Completes Phase II NASH Clinical Trial Recruitment

Melbourne, Australia, February 20 2017: Immuron Limited (ASX: IMC), an Australian biopharmaceutical company focused on oral immunotherapy utilizing polyclonal antibody products to target immune-mediated diseases, today announced that the Company’s IMM-124E Phase II clinical trial for the treatment…

4Dx to publically announce prelim clinical trial data at prestigious world lung imaging event

Dr. Andreas Fouras, founder and CEO of medical technology company 4Dx Limited, will present preliminary clinical data at the prestigious World Lung Imaging Workshop on the 2nd of March at the University of Pennsylvania. The software technology developed…

9th March – Invitation to attend the RMH Executive Women’s Lunch

Research has driven change in medical practice and at Melbourne Health we have a long and proud history of research. While its benefits have accrued to all people, the opportunity to do research has been limited for women…

Mesoblast’s Stem-Cell Treatment Shows Improvement In Rheumatoid Arthritis Patients

Melbourne-based regenerative medicine company Mesoblast Ltd. announced Monday that experiments it was carrying out as a part of stem-cell treatment have led to significant improvements of symptoms and disease activity in rheumatoid arthritis patients who were unable to…

Victorian State Government funds expansion of cancer clinical trials through the Victorian Comprehensive Cancer Centre

Minister for Health, The Hon. Jill Hennessy MP announced today that the Victorian Comprehensive Cancer Centre (VCCC) will receive $20 million over four years in new funding to boost clinical trials and speed up the delivery of new…

TMCx Selects 24 Startups for Spring 2017 Accelerator Program

Three Australian compnaies were succesfully accepted inot the TMC digital health program including CNSDose and Ward Medication Management from Melbourne. The Texas Medical Center (TMC) Innovation Institute today welcomes 24 startups into its accelerator program—its largest class since…

Global Kinetics Corporation Named as One of Fast Company’s 10 Most Innovative Companies in Health

Global Kinetics Corporation was named as one of the top 10 Most Innovative Companies in Health for 2017 by leading US publication Fast Company. The Fast Company list honors growing enterprises that exemplify the very best in nimble…

Ovarian hormones awaken newly discovered breast stem cells

Walter and Eliza Hall Institute researchers have used advanced cellular,bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly…

La Trobe University scientists are preparing to run a world-first clinical trial of a new drug inspired by shark antibodies

The drug, AD-114, is a human protein that is based on the shape of an antibody of a Wobbegong shark. Recent tests on mouse models found AD-114 led to a reduction in fibrosis in the lung and liver,…

Southern Hemisphere First For The New Monash Children’s Hospital

Construction of the world class $250 million Monash Children’s Hospital is complete, with the latest imaging equipment now being installed to make diagnostic scans and procedures less scary and upsetting for children. Minister for Health Jill Hennessy today…

15th – 17th May – AusTrade Smart Health Mission to China

Austrade invites you to join the inaugural Smart Health Mission to China which will profile Australian biotechnology, digital health, mobile health and enabling technologies and solutions in healthcare. The healthcare industry in China is undergoing significant changes as…

Home

News & opinion

Member Directory

Events